Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes

PURPOSE: There are limited clinical data on scanning-beam proton therapy (SPT) in treating locally advanced lung cancer, as most published studies have used passive-scatter technology. There is increasing interest in whether the dosimetric advantages of SPT compared with photon therapy can translate...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Zhenwei, Bowen, Stephen R., Thomas, Hannah M.T., Sasidharan, Balu Krishna, Rengan, Ramesh, Zeng, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Thoracic Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276696/
https://www.ncbi.nlm.nih.gov/pubmed/32529138
http://dx.doi.org/10.1016/j.adro.2020.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276696/
https://www.ncbi.nlm.nih.gov/pubmed/32529138
http://dx.doi.org/10.1016/j.adro.2020.03.001

Ejemplares similares